Ling Peng Selected Research

Ling Peng Research Topics

Disease

78	Neoplasms (Cancer) 04/2024 - 10/2009
25	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023 - 07/2010
14	COVID-19 12/2022 - 01/2020
11	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 11/2019
11	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 02/2009
10	Neoplasm Metastasis (Metastasis) 04/2024 - 03/2010
10	Lung Neoplasms (Lung Cancer) 02/2022 - 01/2014
9	Infections 12/2023 - 01/2005
8	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 08/2009
6	Breast Neoplasms (Breast Cancer) 10/2023 - 03/2010
6	Fibrosis (Cirrhosis) 06/2023 - 01/2019
5	Carcinogenesis 11/2023 - 10/2012
4	Adenocarcinoma of Lung 11/2023 - 04/2015
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 07/2019
4	Pneumonia (Pneumonitis) 02/2022 - 01/2020
4	Adenocarcinoma 10/2021 - 01/2014
4	Hypertension (High Blood Pressure) 10/2020 - 01/2016
3	Glioblastoma (Glioblastoma Multiforme) 02/2024 - 01/2012
3	Carcinoma (Carcinomatosis) 05/2023 - 01/2014
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2013
3	Critical Illness (Critically Ill) 01/2022 - 01/2020
3	Lung Injury 01/2022 - 01/2020
3	Brain Neoplasms (Brain Tumor) 01/2022 - 06/2020
3	Inflammation (Inflammations) 01/2022 - 10/2020
3	Neutropenia 10/2021 - 01/2019
3	Hand-Foot Syndrome 01/2021 - 11/2013
3	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 12/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 04/2024 - 01/2024
2	Acute Kidney Injury (Acute Renal Failure) 05/2023 - 08/2016
2	Cystitis 05/2023 - 01/2021
2	Necrosis 01/2023 - 01/2020
2	Kidney Neoplasms (Kidney Cancer) 01/2023 - 01/2020
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 01/2022
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2022 - 01/2021
2	Respiratory Insufficiency (Respiratory Failure) 07/2022 - 10/2021
2	Disease Progression 10/2021 - 07/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2021 - 01/2014

Drug/Important Bio-Agent (IBA)

21	Dendrimers (Dendrons)IBA 01/2024 - 08/2009
18	Immune Checkpoint InhibitorsIBA 05/2023 - 01/2020
18	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2012
15	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2014
12	Small Interfering RNA (siRNA)IBA 10/2023 - 08/2009
11	Biomarkers (Surrogate Marker)IBA 05/2023 - 01/2016
8	ErbB Receptors (EGF Receptor)IBA 09/2022 - 01/2014
7	Tyrosine Kinase InhibitorsIBA 10/2022 - 01/2017
6	Antiviral Agents (Antivirals)IBA 01/2022 - 02/2009
6	NUPR1 inhibitor ZZW-115IBA 01/2022 - 01/2019
5	Long Noncoding RNAIBA 05/2023 - 01/2019
5	LipidsIBA 01/2023 - 08/2012
5	AlbuminsIBA 08/2022 - 01/2014
5	Intrinsically Disordered ProteinsIBA 10/2021 - 01/2019
4	Messenger RNA (mRNA)IBA 04/2024 - 01/2014
4	LigandsIBA 10/2023 - 01/2021
4	Gemcitabine FDA Link 01/2022 - 04/2010
4	NucleosidesIBA 01/2015 - 12/2010
4	HSP27 Heat-Shock ProteinsIBA 08/2012 - 08/2009
3	CytokinesIBA 01/2024 - 06/2020
3	CollagenIBA 11/2023 - 01/2019
3	PAMAM StarburstIBA 10/2023 - 08/2009
3	Paclitaxel (Taxol)FDA LinkGeneric 05/2023 - 03/2014
3	B7-H1 AntigenIBA 09/2022 - 01/2021
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2018
3	AntigensIBA 01/2022 - 01/2021
3	Bevacizumab (Avastin)FDA Link 01/2022 - 01/2014
3	Angiotensin IIIBA 01/2022 - 01/2020
3	Therapeutic UsesIBA 01/2022 - 06/2020
3	Inosine Diphosphate (IDP)IBA 10/2021 - 01/2019
3	EnzymesIBA 06/2021 - 01/2013
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 06/2015
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020 - 01/2012
3	MicroRNAs (MicroRNA)IBA 01/2016 - 01/2012
3	TriazolesIBA 01/2015 - 10/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 01/2022
2	Lysine (L-Lysine)FDA Link 01/2024 - 01/2023
2	Adenosine Triphosphate (ATP)IBA 11/2023 - 01/2020
2	Becaplermin (PDGF-BB)FDA Link 11/2023 - 06/2020
2	Fibronectins (Fibronectin)IBA 06/2023 - 01/2019
2	Angiogenesis InhibitorsIBA 02/2023 - 01/2020
2	anlotinibIBA 02/2023 - 10/2022
2	Circulating Tumor DNAIBA 01/2023 - 01/2019
2	Programmed Cell Death 1 ReceptorIBA 01/2023 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 11/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 01/2020
2	Immunoglobulin G (IgG)IBA 12/2022 - 01/2020
2	CreatinineIBA 08/2022 - 08/2016
2	Rituximab (Mabthera)FDA Link 07/2022 - 10/2021
2	LipopolysaccharidesIBA 06/2022 - 11/2020
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 06/2020
2	Circular RNAIBA 01/2022 - 01/2021
2	Anaplastic Lymphoma KinaseIBA 01/2022 - 01/2021
2	AntioxidantsIBA 10/2021 - 06/2021

Therapy/Procedure

41	Therapeutics 04/2024 - 03/2010
14	Immunotherapy 10/2023 - 01/2020
11	Drug Therapy (Chemotherapy) 05/2023 - 05/2012
7	Radiotherapy 04/2024 - 06/2020
2	Castration 01/2024 - 03/2012
2	Thoracotomy 01/2023 - 01/2017
2	Molecular Targeted Therapy 01/2023 - 01/2014